Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ferrario

Showing results (51-60 of 828) with videos related to

Pageof 83
Sort By:
Expert Opinion on Therapeutic Patents|October 4, 2018
Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010-2018)Sarfaraz Ahmad, Carlos M Ferrario
European Journal of Preventive Cardiology|July 2, 2019
The health legacy: Promoting and enhancing a socially fair intergenerational transmission of ideal healthGiovanni Veronesi, Marco M Ferrario
Future Cardiology|October 7, 2009
Olmesartan for the treatment of arterial hypertensionChristoph Schindler, Carlos M Ferrario
Giornale Italiano Di Cardiologia (2006)|October 1, 2010
[The contribution of occupational medicine in cardiovascular prevention and return to work of cardiac patients]Marco M Ferrario, Rossana Borchini
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|December 23, 2011
[Workplace health promotion: what evidence of effectiveness?]M M Ferrario, A Borsani
Medicina Clinica|May 17, 2000
[Clinical efficacy of losartan: are there any differences between angiotensin II type I receptor antagonists and other drugs?]J Redon, C M Ferrario
La Medicina Del Lavoro|February 9, 2011
[Heart disease and work: from rehabilitation to return to work]Rossana Borchini, M M Ferrario
American Journal of Physiology. Renal Physiology|April 9, 2010
The ANG-(1-7)/ACE2/mas axis in the regulation of nephron functionCarlos M Ferrario, Jasmina Varagic
The American Journal of Physiology|September 1, 1984
Neurohormonal characteristics of cardiovascular response due to intraventricular hypertonic NaClY Kawano, C M Ferrario
Physical Review Letters|November 13, 2007
Pressure induced friction collapse of rare gas boundary layers sliding over metal surfacesM C Righi, M Ferrario
Pageof 83

Showing results (51-60 of 828) with videos related to

Sort By:
Pageof 83
Expert Opinion on Therapeutic Patents|October 4, 2018
Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010-2018)Sarfaraz Ahmad, Carlos M Ferrario
European Journal of Preventive Cardiology|July 2, 2019
The health legacy: Promoting and enhancing a socially fair intergenerational transmission of ideal healthGiovanni Veronesi, Marco M Ferrario
Future Cardiology|October 7, 2009
Olmesartan for the treatment of arterial hypertensionChristoph Schindler, Carlos M Ferrario
Giornale Italiano Di Cardiologia (2006)|October 1, 2010
[The contribution of occupational medicine in cardiovascular prevention and return to work of cardiac patients]Marco M Ferrario, Rossana Borchini
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|December 23, 2011
[Workplace health promotion: what evidence of effectiveness?]M M Ferrario, A Borsani
Medicina Clinica|May 17, 2000
[Clinical efficacy of losartan: are there any differences between angiotensin II type I receptor antagonists and other drugs?]J Redon, C M Ferrario
La Medicina Del Lavoro|February 9, 2011
[Heart disease and work: from rehabilitation to return to work]Rossana Borchini, M M Ferrario
American Journal of Physiology. Renal Physiology|April 9, 2010
The ANG-(1-7)/ACE2/mas axis in the regulation of nephron functionCarlos M Ferrario, Jasmina Varagic
The American Journal of Physiology|September 1, 1984
Neurohormonal characteristics of cardiovascular response due to intraventricular hypertonic NaClY Kawano, C M Ferrario
Physical Review Letters|November 13, 2007
Pressure induced friction collapse of rare gas boundary layers sliding over metal surfacesM C Righi, M Ferrario
Pageof 83